Page last updated: 2024-12-05

indoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Indoline is a bicyclic aromatic heterocycle consisting of a benzene ring fused to a pyrrolidine ring. It is a colorless liquid with a characteristic amine-like odor. Indoline is a versatile building block in organic synthesis and finds applications in various fields, including pharmaceuticals, agrochemicals, and materials science. It serves as a precursor to various biologically active compounds and is involved in the synthesis of indole alkaloids, such as strychnine and reserpine. Indoline derivatives exhibit a wide range of pharmacological activities, including anti-inflammatory, analgesic, antidepressant, and anticancer properties. Furthermore, indoline derivatives have shown promise as potential therapeutic agents for neurodegenerative diseases, such as Alzheimer's disease. '

indoline: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10328
CHEMBL ID388803
CHEBI ID43295
SCHEMBL ID5629
MeSH IDM0161583

Synonyms (50)

Synonym
BIDD:GT0113
AC-531
dihydroindole
5-20-06-00238 (beilstein handbook reference)
unii-6dpt9ab2nk
6dpt9ab2nk ,
1h-indole, 2,3-dihydro-
indoline
brn 0111915
einecs 207-816-8
1-azaindan
ai3-39164
2,3-dihydro-1h-indole
AG-690/11351758
2,3-dihydroindole
496-15-1
inchi=1/c8h9n/c1-2-4-8-7(3-1)5-6-9-8/h1-4,9h,5-6h
indoline, reagentplus(r), 99%
CHEBI:43295 ,
STK182863
CHEMBL388803
I0033
AKOS000119725
A22086
BBL004502
indoline, 19
bdbm92697
FT-0627227
SCHEMBL5629
PS-5755
DTXSID9052133
2,3-dihydro-1 h-indole
aza-indane
AM85791
indole, 2,3-dihydro-
1h-indole, dihydro-
mfcd00005705
azaindane
CS-W009145
F2190-0413
indoline, purum, >=98.0% (gc)
indoline, vetec(tm) reagent grade, 98%
Q2613101
SY012760
indoline-
P19974
SB66078
(2,4-dimethylphenyl)thio]aceticacid
EN300-19816
Z104475582

Research Excerpts

Overview

The indoline is a scaffold with significantly less historical studies and FDA-approved drugs. It has attracted new interest in drug design and development.

ExcerptReferenceRelevance
"The indoline is a scaffold with significantly less historical studies and FDA-approved drugs and it has attracted new interest in drug design and development."( Indole and Indoline Scaffolds in Antimicrobials: Overview, Synthesis and Recent Advances in Antimicrobial Research.
Lupton, HK; Nieto, MJ, 2021
)
1.49

Effects

ExcerptReferenceRelevance
"Indoline has been reported as an efficient anticancer fragment to design novel anticancer agents."( Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.
Chen, P; Hu, T; Li, MM; Li, YR; Liu, X; Meng, LW; Song, J; Wang, SY; Yu, GX; Zhang, HY; Zhang, SY, 2021
)
1.71

Pharmacokinetics

ExcerptReferenceRelevance
" A small number of indoline fXa inhibitors were profiled in a dog pharmacokinetic model, one of which demonstrated pharmacokinetic parameters similar to that of clinical candidate razaxaban."( Design, structure-activity relationship, and pharmacokinetic profile of pyrazole-based indoline factor Xa inhibitors.
Bai, S; Ellis, CD; He, K; He, MY; Jacobson, IC; Knabb, RM; Lam, PY; Luettgen, JM; Quan, ML; Rossi, KA; Varnes, JG; Wacker, DA; Wexler, RR, 2007
)
0.89

Bioavailability

ExcerptReferenceRelevance
" Some of the antagonists showed good oral bioavailability and/or good brain penetration."( Identification of novel and orally active spiroindoline NPY Y5 receptor antagonists.
Fukami, T; Gao, YD; Gomori, A; Haga, Y; Hidaka, M; Ishihara, A; Iwaasa, H; Kanatani, A; Kitazawa, H; Macneil, DJ; Moriya, M; Nonoshita, K; Okamoto, O; Sakamoto, T; Shibata, T; Takahashi, T; Yang, L, 2009
)
0.61
" In particular, spiropiperidine indoline-substituted diaryl ureas are described as potent, orally bioavailable small-molecule P2Y1 antagonists with improved activity in functional assays and improved oral bioavailability in rats."( Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist.
Abell, LM; Bostwick, JS; Bouthillier, G; Chang, M; Gao, Q; Hiebert, S; Hua, J; Huang, CS; L'Heureux, A; Lam, PY; Liu, E; Lloyd, J; Ma, B; McDonnell, PA; Pi, Z; Price, LA; Qiao, JX; Rehfuss, R; Ruel, R; Schnur, DM; Schumacher, WA; Spronk, SA; Steinbacher, TE; Thibeault, C; Wang, TC; Wexler, RR; Wu, Q; Zheng, J, 2013
)
0.89
" KAE609 was well absorbed and extensively metabolized such that low levels of parent compound (≤11% of the dose) were detected in feces."( Identification of Three Novel Ring Expansion Metabolites of KAE609, a New Spiroindolone Agent for the Treatment of Malaria, in Rats, Dogs, and Humans.
Eggimann, FK; Einolf, HJ; Favara, S; Forseth, RR; Gu, H; He, H; Huskey, SE; Kittelmann, M; Li, H; Lin, MM; Luneau, A; Mangold, JB; Simon, O; Vargas, A; Wang, L; Zhang, J; Zhu, CQ, 2016
)
0.43
" KAE609 was well absorbed and extensively metabolized, such that KAE609 accounted for approximately 32% of the dose in feces."( KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects.
Fredenhagen, A; Huskey, SE; Jain, JP; Jian, Z; Kühnöl, J; Luneau, A; Mangold, JB; Miao, Z; Stein, DS; Sunkara, G; Yang, F; Yang, Z; Zhu, CQ, 2016
)
0.43
" Compound 13b, in particular, has a bioavailability of 22% and achieved a 96% tumor growth inhibition in an MDA-MB-468 xenograft study."( Design and optimization of (3-aryl-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-ones as potent PLK4 inhibitors with oral antitumor efficacy.
Awrey, DE; Ban, F; Beletskaya, I; Edwards, L; Feher, M; Forrest, BT; Green, E; Hodgson, R; Kiarash, R; Laufer, R; Li, SW; Liu, Y; Luo, X; Mak, TW; Mao, G; Mason, JM; Pan, G; Patel, NK; Pauls, HW; Sampson, PB; Wei, X, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" After oral dosing of KAE609 to rats and dogs, the major radioactive component in plasma was KAE609."( Identification of Three Novel Ring Expansion Metabolites of KAE609, a New Spiroindolone Agent for the Treatment of Malaria, in Rats, Dogs, and Humans.
Eggimann, FK; Einolf, HJ; Favara, S; Forseth, RR; Gu, H; He, H; Huskey, SE; Kittelmann, M; Li, H; Lin, MM; Luneau, A; Mangold, JB; Simon, O; Vargas, A; Wang, L; Zhang, J; Zhu, CQ, 2016
)
0.43
" Subjects reported semen discoloration after dosing in prior studies; therefore, semen samples were collected once from each subject to further evaluate this clinical observation."( KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects.
Fredenhagen, A; Huskey, SE; Jain, JP; Jian, Z; Kühnöl, J; Luneau, A; Mangold, JB; Miao, Z; Stein, DS; Sunkara, G; Yang, F; Yang, Z; Zhu, CQ, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
indolesAny compound containing an indole skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
regulation of DNA-templated transcriptionTrp operon repressorEscherichia coli K-12
regulation of DNA-templated transcriptionTrp operon repressorEscherichia coli K-12
negative regulation of DNA-templated transcriptionTrp operon repressorEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
DNA bindingTrp operon repressorEscherichia coli K-12
DNA-binding transcription factor activityTrp operon repressorEscherichia coli K-12
sequence-specific DNA bindingTrp operon repressorEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
cytoplasmTrp operon repressorEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1799822Binding Assay from Article : \\The structural basis for the interaction between L-tryptophan and the Escherichia coli trp aporepressor.\\1987The Journal of biological chemistry, Apr-05, Volume: 262, Issue:10
The structural basis for the interaction between L-tryptophan and the Escherichia coli trp aporepressor.
AID1369963Cytoprotective activity against H2O2-induced oxidative stress in mouse RAW264.7 cells assessed as cell viability at 10 nM incubated for 2 hrs prior to H2O2 addition measured after 24 hrs by MTT assay (Rvb = 68 to 72.8%)2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Synthesis and Biological Evaluation of Derivatives of Indoline as Highly Potent Antioxidant and Anti-inflammatory Agents.
AID281482Inhibition of human intestinal carboxylesterase expressed in sf21 cells up to 100 uM2007Journal of medicinal chemistry, Apr-19, Volume: 50, Issue:8
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
AID281483Inhibition of human liver CE1 expressed in sf21 cells up to 100 uM2007Journal of medicinal chemistry, Apr-19, Volume: 50, Issue:8
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
AID281484Inhibition of rabbit liver carboxylesterase expressed in sf21 cells up to 100 uM2007Journal of medicinal chemistry, Apr-19, Volume: 50, Issue:8
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (421)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (2.61)18.7374
1990's6 (1.43)18.2507
2000's98 (23.28)29.6817
2010's244 (57.96)24.3611
2020's62 (14.73)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.57 (24.57)
Research Supply Index6.06 (2.92)
Research Growth Index5.88 (4.65)
Search Engine Demand Index79.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews9 (2.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other418 (97.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]